JPMorgan Chase & Co. 13D and 13G filings for Twist Bioscience Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-09 1:40 pm Sale | 2024-07-31 | 13G | TWIST BIOSCIENCE CORP COM TWST | JPMORGAN CHASE & CO JPM | 2,509,417 4.300% | -1,953,077 (-43.77%) | Filing |
| 2024-01-25 11:11 am Unchanged | 2023-12-29 | 13G | TWIST BIOSCIENCE CORP COM TWST | JPMORGAN CHASE & CO JPM | 4,462,494 7.700% | 0 (Unchanged) | Filing |
| 2024-01-25 11:10 am Purchase | 2023-12-29 | 13G | TWIST BIOSCIENCE CORP COM TWST | JPMORGAN CHASE & CO JPM | 4,462,494 7.700% | 632,532 (+16.52%) | Filing |
| 2023-01-13 09:28 am Purchase | 2022-12-30 | 13G | TWIST BIOSCIENCE CORP COM TWST | JPMORGAN CHASE & CO JPM | 3,829,962 6.700% | 2,049,403 (+115.10%) | Filing |